These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1876284)

  • 21. Generation of leukotriene B4 by hemodialyzer membranes: a novel index of biocompatibility.
    Strasser T; Schiffl H
    Klin Wochenschr; 1991 Oct; 69(17):808-12. PubMed ID: 1662325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dialyzer geometry during hemodialysis with cuprophane membranes.
    Taylor JE; McLaren M; Mactier RA; Henderson IS; Stewart WK; Belch JJ
    Kidney Int; 1992 Aug; 42(2):442-7. PubMed ID: 1405328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biocompatibility of various dialysis membranes as assessed by coagulation assay.
    Gasparotto ML; Bertoli M; Vertolli U; Ruffatti A; Stoppa ML; Di Landro D; Romagnoli GF
    Contrib Nephrol; 1984; 37():96-100. PubMed ID: 6713885
    [No Abstract]   [Full Text] [Related]  

  • 24. Impaired leucocyte rolling, adhesion and transendothelial migration following cuprophane haemodialysis.
    Thorlacius H; Fernvik E; Gautam N; Lundahl J; Raud J; Jacobson SH; Lindbom L
    Acta Physiol Scand; 1997 Apr; 159(4):277-83. PubMed ID: 9146748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of membrane choice and blood flow pattern on coagulation and heparin requirement--potential consequences on lipid concentrations.
    Sperschneider H; Deppisch R; Beck W; Wolf H; Stein G
    Nephrol Dial Transplant; 1997 Dec; 12(12):2638-46. PubMed ID: 9430865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC; Ringoir SM
    Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
    Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the mechanisms of haemodialysis-induced neutropenia: a study with five new and re-used membranes.
    Heierli C; Markert M; Lambert PH; Kuwahara T; Wauters JP
    Nephrol Dial Transplant; 1988; 3(6):773-83. PubMed ID: 3147419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of cytokines by dialysis membranes in normal whole blood: a new in vitro assay for evaluating membrane biocompatibility.
    Herbelin A; Nguyen AT; Urena P; Descamps-Latscha B
    Blood Purif; 1992; 10(1):40-52. PubMed ID: 1389011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?].
    Sulková S; Lapcík O; Votruba T
    Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Distribution of platelet membrane phospholipids in patients chronically hemodialyzed using cuprophane and cellulose acetate membranes].
    Krawczyk W; Marczewski K; Ledwozyw A; Dmoszyńska A
    Pol Arch Med Wewn; 1994 Jul; 92(1):41-6. PubMed ID: 7971476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukocytes, eosinophils and complement function during hemodialysis with polysulphone and polymethylmethacrylate membranes: comparison with cuprophan and polyacrylonitrile.
    Bergesio F; Monzani G; Manescalchi F; Boccabianca I; Passaleva A; Frizzi V
    Blood Purif; 1988; 6(1):16-26. PubMed ID: 3345242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
    de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
    Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodialysis leucopenia as an index of membrane biocompatibility.
    Aljama P; Garin JM; Torres A; Martin-Malo A; Moreno E; Perez-Calderon R
    Contrib Nephrol; 1984; 37():129-33. PubMed ID: 6713865
    [No Abstract]   [Full Text] [Related]  

  • 35. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyacrilonytrile versus cuprophan membranes for hemodialysis: evaluation of efficacy and biocompatibility by platelet aggregation studies.
    Berrettini M; Buoncristiani U; Parise P; Ballatori E; Nenci GG
    Int J Artif Organs; 1981 Sep; 4(5):218-22. PubMed ID: 7319659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biocompatibility of hemodialysis membranes: a study in healthy subjects.
    Gutierrez A; Alvestrand A; Bergström J; Beving H; Lantz B; Henderson LW
    Blood Purif; 1994; 12(2):95-105. PubMed ID: 7826580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemodialysis activates phospholipase A2 enzyme.
    Vishwanath BS; Fux CA; Uehlinger DE; Frey BM; Franson RC; Frey FJ
    Nephrol Dial Transplant; 1996 Jan; 11(1):109-16. PubMed ID: 8649616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukopenia with different regenerated haemodialysis membranes.
    Ksiaźek A; Sokołowska G; Marczewski K; Solski J
    Int Urol Nephrol; 1984; 16(1):61-7. PubMed ID: 6724830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
    Smeby LC; Widerøe TE; Balstad T; Jørstad S
    Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.